593 Modeling Prostate Cancer Oncogenesis Through Developmental Alterations in Zebrafish

G. Boysen,C. Bourque,J. Huang,C. Barbieri,N. Kitabayashi,Z. Chen,F. Demichelis,W. Hussain,Y. Houvras,M. Rubin

DOI: https://doi.org/10.1016/s0959-8049(12)71250-9

IF: 10.002

2012-01-01

European Journal of Cancer

Abstract:Introduction: Acute lymphoblastic leukemia (ALL) is the most common childhood malignancy, accounting for 25% of all childhood malignancies in the Nordic countries.DNA methylation plays an important role as a modulator of gene expression and in the control of cell differentiation, thus DNA methylation could be one of the factors that enhance the malignant transformation of precursor blood cells into leukemic cells.DNA methylation may also contribute to the variation between ALL patients in clinical outcome and response to treatment.Materials and Methods: Using Infinium Methylation BeadChips, we determined the methylation levels of >450,000 CpG sites in 1,002 samples, including 850 bone marrow samples collected at the time of ALL diagnosis from patients in the Nordic countries.Follow-up bone marrow samples from ALL patients taken during remission and purified CD19+, CD3+, and CD34+ cells isolated from healthy blood donors were included as controls.Four representative ALL patients were subjected to whole-genome bisulfite sequencing (BS-seq) at high coverage.Results and Discussion: The DNA methylation levels (b-values) determined with the BeadChips were highly correlated to those measured by BS-seq of DNA from the same individuals (Pearson's R >0.95).The ALL samples displayed higher variability and a distinct overall increase in methylation levels compared to healthy blood cell populations.Over 25k of the 450k CpG sites were differentially methylated in ALL cells with a median absolute difference in methylation levels >30% compared to the controls.Of these, 79% were hypermethylated in the ALL cells and predominantly located in CpG islands and nearby the transcription start site.In contrast, the majority of the hypomethylated sites were located outside of CpG islands, in particular in CpG sites flanking islands and in gene bodies.Currently, multivariate analysis of variation in DNA methylation levels across the genome against clinical outcome is underway. Conclusion:Preliminary results show that the array-based assay and BSseq is highly reproducible.Several methylation changes that will serve as candidates for further investigation into the molecular role of DNA methylation in ALL etiology and clinical outcome of ALL patients have been identified.This study has been approved by the Nordic Society for Pediatric Hematology and Oncology.